Stocks are rising this morning around the world, with the KOSPI and DAX both up around 1% and Shanghai up nearly 2%. It is essential to recognize this because it indicates the rally here in the US is not alone. The big question is what phase of this rally are we in? Is the middle or nearing the end? Very hard to tell, of course, but what we do know is that a few of these markets are at inflection points. It means they continue higher or turn the other way. 

South Korea (EWY)

The KOSPI is at a multi-year downtrend that has seen the index fail multiple times over the years. So is this a significant level for South Korea? Yes. So is South Korea at an inflection point, yes. 

NASDAQ 100 (QQQ)

The QQQ is at an inflection point of there own. Either the ETF is in the midst of a change in trend, or is the upper part of the range. Either we are going sharply higher from here or sharply lower. I’m not sure there is an in-between. 

S&P 500 (SPY)

The SPY is either about to break out or turn lower. The ETF is sitting at its own inflection point, which is the downtrend off the February highs. 

Pepsi (PEP)

Pepsi reported better than expected results this morning on the strength of its Frito-Lay brands. But guess what the company is giving no guidance. How I hope this isn’t the trend for every company this quarter. The stock is rising to resistance at $139.50, and just like everything else, finds itself at an inflection point. 

UBER (UBER)

Well, if you thought Uber was a riding sharing business, it is now only half a ride-sharing company, with food delivery the other half. I don’t know how that changes the stock valuation, but yes, something to think about. Given the virus, I believe that over time, we find that riding sharing continues to shrink as a percentage of the pie. I still think this one heads lower. 

Pfizer (PFE)

Pfizer is rising this morning on news two of its vaccine candidates will get FDA fast track destination. So? Who cares? It doesn’t mean anything. So instead of taking 12 months for approval, it will take 6?! Why is the stock is trading up on this news. Any die-hard biotech investors must be so frustrated how this market reacts to non-news headlines, that move the entire market! I wonder if PFE can get above $34.90.